42 results
8-K
EX-99.2
MAIA
MAIA Biotechnology Inc
4 Jun 24
Regulation FD Disclosure
4:06pm
+ tumor types Leadership roles at Bayer (Nexavar), Astellas (Tarceva, Xtandi), Cephalon (Treanda), Novartis (Zometa), and Incyte (Jakafi) Scan QR Code
8-K
EX-99.1
MAIA
MAIA Biotechnology Inc
4 Jun 24
Regulation FD Disclosure
4:06pm
Development, Oncology CFO for privately held and across 20+ tumor types with 120+ publications publicly traded companies Leadership roles at Head
424B5
MAIA
MAIA Biotechnology Inc
14 Feb 24
Prospectus supplement for primary offering
5:18pm
with the Vesting.
Our Leadership Team
We have assembled an experienced management team with deep research, development, and commercialization … maintain four issued patents and have sixteen (16) pending applications.
Our Leadership Team
We have assembled an experienced management team with deep
424B5
11r9oawmevmdtiknn9
17 Nov 23
Prospectus supplement for primary offering
9:06am
424B5
9uhfvqlyg5ditjx19ekd
1 Sep 23
Prospectus supplement for primary offering
4:30pm
S-3
2thuugl0xvj5
14 Aug 23
Shelf registration
6:05pm
FWP
f4z9viz
11 Jul 23
Free writing prospectus
12:42pm
FWP
ihs3p
9 Jun 23
Free writing prospectus
6:47am
DRS
dtl qc12gro
1 Jun 23
Draft registration statement
12:00am
424B4
51qeryk 6ydfocjsrd41
25 Apr 23
Prospectus supplement with pricing info
7:45pm
FWP
u4959xq7vp
20 Apr 23
Free writing prospectus
9:38am
DEF 14A
f7o7f p09o0zpcpr
19 Apr 23
Definitive proxy
4:06pm
FWP
6cjkborqtgr94j9z26
18 Apr 23
Free writing prospectus
3:08pm
FWP
1n603
11 Apr 23
Free writing prospectus
8:30am
FWP
d9e7r
6 Apr 23
Free writing prospectus
6:24pm